Sponsored by:

Molecular Imaging: Page 287

PET/CT helps with bone scans in staging breast cancer
By Wayne Forrest
Sunday, November 25 | 11:45 a.m.-11:55 a.m. | SSA18-07 | Room S505ABPET/CT can provide sufficient information from bone scans for the staging or restaging of breast cancer, according to a retrospective study by researchers from University Hospital Mannheim.
November 7, 2012
PET/MRI offers diagnostic accuracy for lymph node staging
By Wayne Forrest
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA12-04 | Room S504CDPET/MRI provides sufficient diagnostic accuracy for lymph node metastases detection, while diffusion-weighted MRI images are inaccurate for staging in head and neck cancer patients, according to researchers from the University of Düsseldorf.
November 7, 2012
FDG-PET/CT beats conventional imaging for breast cancer staging
By Wayne Forrest
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABGerman researchers retrospectively compared the diagnostic accuracy of whole-body FDG-PET/CT for initial breast cancer staging with the accuracy of conventional imaging using several different modalities. They will present their findings in this Sunday presentation.
November 7, 2012
Slow growth expected for U.S. imaging market
By AuntMinnie.com staff writers
The U.S. diagnostic imaging system market will grow slowly to reach a total size of $4.5 billion by 2017, according to a new report from market research firm Millennium Research Group.
November 5, 2012
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
November 4, 2012
CMS meeting to review PET amyloid coverage
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) will convene an advisory committee meeting in January 2013 to review its policies regarding coverage of PET imaging studies of beta amyloid in the brain.
October 31, 2012
Lantheus extends molybdenum-99 supply contract
By AuntMinnie.com staff writers
Diagnostic imaging agent developer Lantheus Medical Imaging has extended its contract with NTP Radioisotopes, a subsidiary of the South African Nuclear Energy Corporation.
October 30, 2012
Navidea tries again with Lymphoseek NDA
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has resubmitted a new drug application (NDA) to the U.S. Food and Drug Administration for its Lymphoseek radiopharmaceutical.
October 30, 2012
Dilon touts low-dose breast imaging results
By AuntMinnie.com staff writers
Breast-specific gamma imaging provider Dilon Diagnostics said that new research shows its gamma camera can perform molecular breast imaging at half of the normal radiation dose by halving the amount of radiotracer, with no loss of diagnostic ability.
October 25, 2012
Naviscan signs PEM distribution deal
By AuntMinnie.com staff writers
PET developer Naviscan has entered into a sales agreement in which Ledford Medical Electronics will augment Naviscan's U.S. direct sales staff in distributing its positron emission mammography (PEM) scanner.
October 25, 2012
NaF-PET/CT detects bone mets in prostate cancer patients
By Wayne Forrest
The use of PET/CT with a sodium fluoride (NaF) radiopharmaceutical produces high sensitivity, suggesting that the modality can be beneficial in detecting bone metastases caused by prostate cancer, according to a study published in the November issue of the American Journal of Roentgenology.
October 25, 2012
2012 10 25 15 14 34 684 2012 11 Ajr Mosavi B Thumb
NCM to collaborate with Genentech
By AuntMinnie.com staff writers
PET radiopharmaceutical developer NCM USA said it has signed a technology development and supply agreement with Genentech.
October 23, 2012
Previous Page
Page 287 of 615
Next Page